- Home
- BWAY vs NCZ Comparison
BWAY vs NCZ Comparison
Compare BWAY & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- NCZ
- Stock Information
- Founded
- BWAY 2003
- NCZ 2003
- Country
- BWAY Israel
- NCZ United States
- Employees
- BWAY N/A
- NCZ N/A
- Industry
- BWAY Medical/Dental Instruments
- NCZ Finance Companies
- Sector
- BWAY Health Care
- NCZ Finance
- Exchange
- BWAY Nasdaq
- NCZ Nasdaq
- Market Cap
- BWAY 245.2M
- NCZ 228.3M
- IPO Year
- BWAY 2019
- NCZ N/A
- Fundamental
- Price
- BWAY $13.00
- NCZ $12.90
- Analyst Decision
- BWAY Strong Buy
- NCZ
- Analyst Count
- BWAY 2
- NCZ 0
- Target Price
- BWAY $14.25
- NCZ N/A
- AVG Volume (30 Days)
- BWAY 53.7K
- NCZ 533.0K
- Earning Date
- BWAY 08-05-2025
- NCZ 01-01-0001
- Dividend Yield
- BWAY N/A
- NCZ 12.16%
- EPS Growth
- BWAY N/A
- NCZ N/A
- EPS
- BWAY 0.08
- NCZ N/A
- Revenue
- BWAY $43,457,000.00
- NCZ N/A
- Revenue This Year
- BWAY $351.53
- NCZ N/A
- Revenue Next Year
- BWAY $21.84
- NCZ N/A
- P/E Ratio
- BWAY $64.24
- NCZ N/A
- Revenue Growth
- BWAY 26.86
- NCZ N/A
- 52 Week Low
- BWAY $5.98
- NCZ $2.50
- 52 Week High
- BWAY $13.66
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- BWAY 65.17
- NCZ 72.69
- Support Level
- BWAY $12.76
- NCZ $12.78
- Resistance Level
- BWAY $13.66
- NCZ $12.95
- Average True Range (ATR)
- BWAY 0.51
- NCZ 0.14
- MACD
- BWAY 0.02
- NCZ 0.02
- Stochastic Oscillator
- BWAY 76.73
- NCZ 93.51
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.